Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease

Elena Nobili, M. Dolores Salvado, Lasse Folkersen, Laura Castiglioni, Jens Kastrup, Anders Wetterholm, Elena Tremoli, Göran K. Hansson, Luigi Sironi, Jesper Z. Haeggström, Anders Gabrielsen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Cysteinyl-leukotrienes (cys-LT) are powerful spasmogenic and immune modulating lipid mediators involved in inflammatory diseases, in particular asthma. Here, we investigated whether cys-LT signaling, in the context of atherosclerotic heart disease, compromises the myocardial microcirculation and its response to hypoxic stress. To this end, we examined Apoe-/- mice fed a hypercholesterolemic diet and analysed the expression of key enzymes of the cys-LT pathway and their receptors (CysLT1/CysLT2) in normal and hypoxic myocardium as well as the potential contribution of cys-LT signaling to the acute myocardial response to hypoxia. Methods and principal findings: Myocardial biopsies from Apoe-/- mice demonstrated signs of chronic inflammation with fibrosis, increased apoptosis and expression of IL-6, as compared to biopsies from C57BL/6J control mice. In addition, we found increased leukotriene C4 synthase (LTC4S) and CysLT1 expression in the myocardium of Apoe-/- mice. Acute bouts of hypoxia further induced LTC4S expression, increased LTC4S enzyme activity and CysLT1 expression, and were associated with increased extension of hypoxic areas within the myocardium. Inhibition of cys-LT signaling by treatment with montelukast, a selective CysLT1 receptor antagonist, during acute bouts of hypoxic stress reduced myocardial hypoxic areas in Apoe-/- mice to levels equal to those observed under normoxic conditions. In human heart biopsies from 14 patients with chronic coronary artery disease mRNA expression levels of LTC4S and CysLT1 were increased in chronic ischemic compared to non-ischemic myocardium, constituting a molecular basis for increased cys-LT signaling. Conclusion: Our results suggest that CysLT1 antagonists may have protective effects on the hypoxic heart, and improve the oxygen supply to areas of myocardial ischemia, for instance during episodes of sleep apnea.

Original languageEnglish
Article numbere41786
JournalPLoS One
Volume7
Issue number7
DOIs
Publication statusPublished - Jul 25 2012

Fingerprint

leukotrienes
heart diseases
hypoxia
Heart Diseases
Apolipoproteins E
Biopsy
Myocardium
myocardium
montelukast
mice
biopsy
Microcirculation
Oxygen supply
Sleep Apnea Syndromes
Enzyme activity
Enzymes
Nutrition
antagonists
Myocardial Ischemia
heart

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Nobili, E., Salvado, M. D., Folkersen, L., Castiglioni, L., Kastrup, J., Wetterholm, A., ... Gabrielsen, A. (2012). Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease. PLoS One, 7(7), [e41786]. https://doi.org/10.1371/journal.pone.0041786

Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease. / Nobili, Elena; Salvado, M. Dolores; Folkersen, Lasse; Castiglioni, Laura; Kastrup, Jens; Wetterholm, Anders; Tremoli, Elena; Hansson, Göran K.; Sironi, Luigi; Haeggström, Jesper Z.; Gabrielsen, Anders.

In: PLoS One, Vol. 7, No. 7, e41786, 25.07.2012.

Research output: Contribution to journalArticle

Nobili, E, Salvado, MD, Folkersen, L, Castiglioni, L, Kastrup, J, Wetterholm, A, Tremoli, E, Hansson, GK, Sironi, L, Haeggström, JZ & Gabrielsen, A 2012, 'Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease', PLoS One, vol. 7, no. 7, e41786. https://doi.org/10.1371/journal.pone.0041786
Nobili E, Salvado MD, Folkersen L, Castiglioni L, Kastrup J, Wetterholm A et al. Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease. PLoS One. 2012 Jul 25;7(7). e41786. https://doi.org/10.1371/journal.pone.0041786
Nobili, Elena ; Salvado, M. Dolores ; Folkersen, Lasse ; Castiglioni, Laura ; Kastrup, Jens ; Wetterholm, Anders ; Tremoli, Elena ; Hansson, Göran K. ; Sironi, Luigi ; Haeggström, Jesper Z. ; Gabrielsen, Anders. / Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease. In: PLoS One. 2012 ; Vol. 7, No. 7.
@article{40616896e797480cb3d1f95c00339cf8,
title = "Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease",
abstract = "Background: Cysteinyl-leukotrienes (cys-LT) are powerful spasmogenic and immune modulating lipid mediators involved in inflammatory diseases, in particular asthma. Here, we investigated whether cys-LT signaling, in the context of atherosclerotic heart disease, compromises the myocardial microcirculation and its response to hypoxic stress. To this end, we examined Apoe-/- mice fed a hypercholesterolemic diet and analysed the expression of key enzymes of the cys-LT pathway and their receptors (CysLT1/CysLT2) in normal and hypoxic myocardium as well as the potential contribution of cys-LT signaling to the acute myocardial response to hypoxia. Methods and principal findings: Myocardial biopsies from Apoe-/- mice demonstrated signs of chronic inflammation with fibrosis, increased apoptosis and expression of IL-6, as compared to biopsies from C57BL/6J control mice. In addition, we found increased leukotriene C4 synthase (LTC4S) and CysLT1 expression in the myocardium of Apoe-/- mice. Acute bouts of hypoxia further induced LTC4S expression, increased LTC4S enzyme activity and CysLT1 expression, and were associated with increased extension of hypoxic areas within the myocardium. Inhibition of cys-LT signaling by treatment with montelukast, a selective CysLT1 receptor antagonist, during acute bouts of hypoxic stress reduced myocardial hypoxic areas in Apoe-/- mice to levels equal to those observed under normoxic conditions. In human heart biopsies from 14 patients with chronic coronary artery disease mRNA expression levels of LTC4S and CysLT1 were increased in chronic ischemic compared to non-ischemic myocardium, constituting a molecular basis for increased cys-LT signaling. Conclusion: Our results suggest that CysLT1 antagonists may have protective effects on the hypoxic heart, and improve the oxygen supply to areas of myocardial ischemia, for instance during episodes of sleep apnea.",
author = "Elena Nobili and Salvado, {M. Dolores} and Lasse Folkersen and Laura Castiglioni and Jens Kastrup and Anders Wetterholm and Elena Tremoli and Hansson, {G{\"o}ran K.} and Luigi Sironi and Haeggstr{\"o}m, {Jesper Z.} and Anders Gabrielsen",
year = "2012",
month = "7",
day = "25",
doi = "10.1371/journal.pone.0041786",
language = "English",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - Cysteinyl leukotriene signaling aggravates myocardial hypoxia in experimental atherosclerotic heart disease

AU - Nobili, Elena

AU - Salvado, M. Dolores

AU - Folkersen, Lasse

AU - Castiglioni, Laura

AU - Kastrup, Jens

AU - Wetterholm, Anders

AU - Tremoli, Elena

AU - Hansson, Göran K.

AU - Sironi, Luigi

AU - Haeggström, Jesper Z.

AU - Gabrielsen, Anders

PY - 2012/7/25

Y1 - 2012/7/25

N2 - Background: Cysteinyl-leukotrienes (cys-LT) are powerful spasmogenic and immune modulating lipid mediators involved in inflammatory diseases, in particular asthma. Here, we investigated whether cys-LT signaling, in the context of atherosclerotic heart disease, compromises the myocardial microcirculation and its response to hypoxic stress. To this end, we examined Apoe-/- mice fed a hypercholesterolemic diet and analysed the expression of key enzymes of the cys-LT pathway and their receptors (CysLT1/CysLT2) in normal and hypoxic myocardium as well as the potential contribution of cys-LT signaling to the acute myocardial response to hypoxia. Methods and principal findings: Myocardial biopsies from Apoe-/- mice demonstrated signs of chronic inflammation with fibrosis, increased apoptosis and expression of IL-6, as compared to biopsies from C57BL/6J control mice. In addition, we found increased leukotriene C4 synthase (LTC4S) and CysLT1 expression in the myocardium of Apoe-/- mice. Acute bouts of hypoxia further induced LTC4S expression, increased LTC4S enzyme activity and CysLT1 expression, and were associated with increased extension of hypoxic areas within the myocardium. Inhibition of cys-LT signaling by treatment with montelukast, a selective CysLT1 receptor antagonist, during acute bouts of hypoxic stress reduced myocardial hypoxic areas in Apoe-/- mice to levels equal to those observed under normoxic conditions. In human heart biopsies from 14 patients with chronic coronary artery disease mRNA expression levels of LTC4S and CysLT1 were increased in chronic ischemic compared to non-ischemic myocardium, constituting a molecular basis for increased cys-LT signaling. Conclusion: Our results suggest that CysLT1 antagonists may have protective effects on the hypoxic heart, and improve the oxygen supply to areas of myocardial ischemia, for instance during episodes of sleep apnea.

AB - Background: Cysteinyl-leukotrienes (cys-LT) are powerful spasmogenic and immune modulating lipid mediators involved in inflammatory diseases, in particular asthma. Here, we investigated whether cys-LT signaling, in the context of atherosclerotic heart disease, compromises the myocardial microcirculation and its response to hypoxic stress. To this end, we examined Apoe-/- mice fed a hypercholesterolemic diet and analysed the expression of key enzymes of the cys-LT pathway and their receptors (CysLT1/CysLT2) in normal and hypoxic myocardium as well as the potential contribution of cys-LT signaling to the acute myocardial response to hypoxia. Methods and principal findings: Myocardial biopsies from Apoe-/- mice demonstrated signs of chronic inflammation with fibrosis, increased apoptosis and expression of IL-6, as compared to biopsies from C57BL/6J control mice. In addition, we found increased leukotriene C4 synthase (LTC4S) and CysLT1 expression in the myocardium of Apoe-/- mice. Acute bouts of hypoxia further induced LTC4S expression, increased LTC4S enzyme activity and CysLT1 expression, and were associated with increased extension of hypoxic areas within the myocardium. Inhibition of cys-LT signaling by treatment with montelukast, a selective CysLT1 receptor antagonist, during acute bouts of hypoxic stress reduced myocardial hypoxic areas in Apoe-/- mice to levels equal to those observed under normoxic conditions. In human heart biopsies from 14 patients with chronic coronary artery disease mRNA expression levels of LTC4S and CysLT1 were increased in chronic ischemic compared to non-ischemic myocardium, constituting a molecular basis for increased cys-LT signaling. Conclusion: Our results suggest that CysLT1 antagonists may have protective effects on the hypoxic heart, and improve the oxygen supply to areas of myocardial ischemia, for instance during episodes of sleep apnea.

UR - http://www.scopus.com/inward/record.url?scp=84864363914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864363914&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0041786

DO - 10.1371/journal.pone.0041786

M3 - Article

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e41786

ER -